doi: 10.3389/fnut.2025.1739173 Received 04 November 2025 Revised 04 December 2025 Accepted 15 December 2025 Published 02 April 2026 Volume 12 - 2025 Edited by Eric Gumpricht, Independent Researcher, Gilbert, AZ, United States Reviewed by Etore Signini, Federal University of So Carlos, Brazil Lara Russo, National Research Council (CNR), Italy Updates Copyright 2026 Lin, Zhang, Pu and Peng
Patients with these risk factors should discuss screening and supplementation strategies with their GP, particularly if experiencing symptoms such as fatigue, paraesthesia, glossitis, or cognitive changes suggestive of deficiency
Comparison decision path Use this comparison to narrow the provider review question Direct answer GoodRx vs Mochi Health: GLP-1 Program Comparison 2026 should help you decide which option deserves a clinical review, not force a one-size answer
Frequently Asked Questions How Do I Qualify For Savings